PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 28 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Extracts of G. officinalis (devoid of alkaloids) at 600 mg/kg in rats decreased blood glucose and glycosylated hemoglobin, increased glucose tolerance, and increased plasma insulin and C-peptide [PMID: 34572994].
Galega herb (10% w/w in diet) caused significant reduction in body weight in both normal and genetically obese (ob/ob) mice over 28 days [PMID: 10632090].
While used as a galactogogue, no scientifically valid clinical trials support this use, though some old, poorly controlled studies found an effect [PMID: 30000876].
Ethanolic (60%) extracts exhibited significant inhibition on the growth of both Gram-positive and Gram-negative bacteria [PMID: 11483386].
Pregnancy & lactation
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 28776081 (2017) — Metformin: historical overview. · Diabetologia
- 2.PMID: 21241070 (2011) — Clinical pharmacokinetics of metformin. · Clinical pharmacokinetics
- 3.PMID: 30000876 (2006) — Specificity in Legume-Rhizobia Symbioses. · International journal of molecular sciences
- 4.PMID: 30126348 (2019) — Review of Biguanide (Metformin) Toxicity. · Journal of intensive care medicine
- 5.PMID: 35853554 (2022) — Two Cases of Suspected Poisoning With Goat's Rue (Galega officinalis L.) in Horses. · Journal of equine veterinary science